SEARCH

SEARCH BY CITATION

References

  • 1
    Lima AA. Tropical diarrhea: new developments in travelers’ diarrhea. Curr Opin Infect Dis 2001; 14: 547552.
  • 2
    Ericsson CD. Travelers’ diarrhea. Int J Antimicrob Agents 2003: 21: 116124.
  • 3
    Scott DA, Tribble DR. Protection against Campylobacter infection and vaccine development. In: NachamkinI, BlaserMJ, eds. Chapter 15: Campylobacter; 2nd Ed. Washington DC: American Society of Microbiology, 2000: 303319.
  • 4
    Rendi-Wagner P, Kollaritsch H. Drug prophylaxis for travelers’ diarrhea. Clin Infect Dis 2002; 34: 628633.
  • 5
    Cheng AC, Thielman NM. Update on traveler’s diarrhea. Curr Infect Dis Rep 2002; 4: 7077.
  • 6
    Sanders JW, Putnam SD, Gould P, Tribble DR. Military importance of diarrhea: lessons from the Middle East. Curr Opin Gastroenterol 2005; 21: 914.
  • 7
    Sanders JW, Putnam SD, Gould P, Tribble DR. Diarrheal illness among deployed US military personnel during Operation Bright Star 2001—Egypt. Diagn Microbiol Infect Dis 2005; 52: 8590.
  • 8
    Lim ML, Murphy GS, Calloway M, Tribble D. History of US military contributions to the study of diarrheal diseases. Military Med 2005; 170: 3038.
  • 9
    Cunningham C, Lee CH. Myocarditis related to Campylobacter jejuni infection. BMC Infect Dis 2003; 3: 16.
  • 10
    Reimund JM, Muller CD, Finck G, et al. Factors contributing to infectious diarrhea-associated pancreatic enzyme alterations. Gastroenterol Clin Biol 2005; 29: 24753.
  • 11
    Butzler JP. Campylobacter: from obscurity to celebrity. Clin Microbiol Infect 2004; 10: 868876.
  • 12
    Ang JY, Nachman S. Campylobacter infections. 2003. Available at: http://www.emedicine.com/ped/topic2697.htm. (Accessed 2005 Aug 16)
  • 13
    Koide T, Yamazaki M, Onishi Y, et al. A case of Guillain-Barré syndrome after the travel in southeast Asia—isolation of Campylobacter jejuni PEN 5 serotype. Rinsho Shinkeigaku 1997; 37: 4143.
  • 14
    Castelli F, Pezzoli C, Tomasoni L. Epidemiology of traveler’s diarrhea. J Travel Med 2001; 8(Suppl 2): S26S30.
  • 15
    Adachi JA, Ericsson CD, DuPont HL. Chapter 7: Relative importance of pathogens and non-infectious causes. In: EricssonCD, DuPontHL, and SteffenR, eds. Travelers’ Diarrhea, 1st Ed. London: Decker, 2003; 100109.
  • 16
    Thielman NM, Guerrant RL. Acute infectious diarrhea. N Engl J Med 2004; 350: 3847.
  • 17
    Hoge CW, Shlim DR, Echeverria P, et al. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. JAMA 1996; 275:533538.
  • 18
    Van Herck K, Van Damme P, Castelli F, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med 2004; 11: 38.
  • 19
    Hamer DH, Connor BA. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med 2004; 11: 2326.
  • 20
    Toovey S, Jamieson A, Holloway M. Traveler’s knowledge, attitudes, and practices on the prevention of infectious diseases: results from a study at Johannesburg International Airport. J Travel Med 2004; 11: 1622.
  • 21
    Schunk M, Wachinger W, Nothdurft HD. Vaccination status and prophylactic measures of travelers from Germany to subtropical and tropical areas: results of an airport survey. J Travel Med 2001; 8: 260262.
  • 22
    Wilder-Smith A, Khairullah NS, Song JH, et al. Travel health knowledge, attitudes and practices among Australasian travelers. J Travel Med 2004; 11: 915.
  • 23
    Van Herck K, Zuckerman J, Castelli F, et al. Traveler’s knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study. J Travel Med 2003; 10: 7578.
  • 24
    Lobel HO, Baker MA, Gras FA, et al. Use of malaria prevention measures by North American and European travelers to East Africa. J Travel Med 2001; 8: 167117.
  • 25
    Ropers G, Krause G, Tiemann F, et al. Nationwide survey of the role of travel medicine in primary care in Germany. J Travel Med 2004; 11: 28729.
  • 26
    Scerpella EG, Sanchez JL, Mathewson JJ, et al. Safety, immunogenicity, and protective efficacy of the whole cell/recombinant B subunit oral cholera vaccine response against traveler’s diarrhea. J Travel Med 1995; 2: 2227.
  • 27
    Leyten EM, Soonawala D, Schultsz C, et al. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers’ diarrhea in a randomised double-blind, placebo-controlled study. Vaccine 2005; 23: 51205126.